Eisai Pharmaceuticals India Pvt. Ltd
3 clinical trials · Sponsor
◉ Watch Eisai Pharmaceuticals India Pvt. Ltd
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Safety and Efficacy of Lenvatinib as First-line Treatment in Participants With Unresectable HCC (NCT04297254) | Eisai Pharmaceuticals India Pvt. Ltd | 2021-02-04 |
| A Study to Assess Safety and Efficacy of Perampanel in Indian Participants as an Adjunctive Treatment in Partial Onset Seizures With or Without Secondary Generalized Seizures in Participants With Epilepsy Aged 12 Years or Older (NCT03836924) | Eisai Pharmaceuticals India Pvt. Ltd | 2019-02-18 |
| A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer (NCT03573960) | Eisai Pharmaceuticals India Pvt. Ltd | 2018-04-01 |
Track Eisai Pharmaceuticals India Pvt. Ltd automatically
Every clearance here is in the API, with alerts when new ones post.